| 06/18 | FORM 8.3 - THE VANGUARD GROUP, INC. : Xeris Pharmaceuticals, Inc | DJ |
| 06/18 | FORM 8.3 - THE VANGUARD GROUP, INC. : UDG Healthcare plc | DJ |
| 06/18 | FORM 8.3 - THE VANGUARD GROUP, INC. : Strongbridge Biopharma plc | DJ |
| 06/18 | Correction to Becton Dickinson Outlook Article on Feb. 6, 2020 | DJ |
| 06/18 | Hutchmed (China) Treatment Approved in China for Pancreatic Tumors | DJ |
| 06/18 | FORM 8.3 - THE VANGUARD GROUP, INC. : Spire Healthcare Group plc | DJ |
| 06/18 | ASTRAZENECA : EU loses bid for speedier AstraZeneca vaccine deliveries | RE |
| 06/18 | Bristol Myers Gets EC Approval for Onureg in Acute Myeloid Leukemia | DJ |
| 06/18 | AstraZeneca Ordered to Deliver Vaccine Doses to EU Amid Lawsuit -- Update | DJ |
| 06/18 | Orphazyme Shares Plummet After FDA Turns Away Arimoclomol Application | DJ |
| 06/18 | Edesa Biotech Covid-19 Drug Candidate Gets Positive Review from Independent Data Group | DJ |
| 06/18 | CROSSJECT : Another good piece of news for the group | AL |
| 06/18 | PRESS RELEASE : BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma | DJ |
| 06/18 | ASTRAZENECA : S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 people | RE |
| 06/18 | PRESS RELEASE : APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 135% | DJ |
| 06/18 | MODERNA : Japan Inc joins COVID-19 vaccination push as Olympics loom | RE |
| 06/17 | ASTRAZENECA : S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 people | RE |
| 06/17 | MODERNA : U.S. says delivered one million COVID-19 vaccine doses to Canada on Thursday | RE |
| 06/17 | MODERNA : Taiwan says 240,000 COVID-19 Moderna doses to arrive on Friday | RE |
| 06/17 | Hutchmed (China) Seeks to Raise More Than US$600 Million in Hong Kong IPO | DJ |
| 06/17 | EISAI : Bristol-Myers and Eisai to jointly develop, market cancer drug | RE |
| 06/17 | MODERNA : U.S. CDC delays meet on heart risk from COVID-19 shots due to Juneteenth holiday | RE |
| 06/17 | Canada Vaccine Panel Recommends Against AstraZeneca PLC for Second Dose | DJ |
| 06/17 | CureVac may let contractors make rival vaccines if own shot fails -CEO | RE |
| 06/17 | Danaher on Pace for Largest Percent Increase Since April 2020 -- Data Talk | DJ |
| 06/17 | MODERNA : U.S. administers nearly 315 mln doses of COVID-19 vaccines - CDC | RE |
| 06/17 | MODERNA : U.S. CDC Says Delivered About 377.2 Mln Doses Of Covid-19 Vaccine As Of June 17 | RE |
| 06/17 | DGAP-PVR : Gerresheimer AG: Correction of a -2- | DJ |
| 06/17 | CureVac may let contractors make rival vaccines if own shot fails - CEO | RE |
| 06/17 | DGAP-PVR : Gerresheimer AG: Release according to -2- | DJ |
| 06/17 | Nanox Imaging Shares Rise 15% on 510(k) Application for Imaging System | DJ |
| 06/17 | Danaher to Buy Aldevron for About $9.6 Billion in Cash | DJ |
| 06/17 | SIEMENS HEALTHINEERS : Kepler Cheuvreux reaffirms its Buy rating | MD |
| 06/17 | AcelRx in Agreement with FDA On Dsuvia Promotional Materials Warning Letter | DJ |
| 06/17 | Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer | DJ |
| 06/17 | Turning Point Gets FDA Orphan Designation for TPX-0022 in Gastric Cancer | DJ |
| 06/17 | ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating | MD |
| 06/17 | FRESENIUS SE : Deutsche Bank reiterates its Neutral rating | MD |
| 06/17 | QIAGEN NV : Deutsche Bank reiterates its Buy rating | MD |
| 06/17 | NOVARTIS AG : Deutsche Bank keeps its Buy rating | MD |
| 06/17 | Synlogic, Roche in Bowel-Disease Collaboration | DJ |
| 06/17 | Bayer to Continue to Work With Curevac After Covid-19 Study Disappointment | DJ |
| 06/17 | Applied Therapeutics Gets FDA Fast-Track Designation for AT-007 in Galactosemia | DJ |
| 06/17 | Aerie Completes Enrollment of Phase 3 Glaucoma Study in Japan | DJ |
| 06/17 | SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and voting rights making up the issued capital | DJ |
| 06/17 | SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de droits de vote composant le capital social | DJ |
| 06/17 | Redx Pharma Gets $4 Million as Milestone Payment From AstraZeneca | DJ |
| 06/17 | PRESS RELEASE : Heidelberg Pharma Announces Participation at Various Conferences | DJ |
| 06/17 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 06/17 | GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating | MD |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
